OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 351 - 360 of 796 studies

Cancer and neoplasms

Randomised controlled trial evaluating effectiveness of neoadjuvant endocrine treatment in post-menopausal women (EndoNET)

RESEARCH QUESTION: In post-menopausal women who will not require chemotherapy for >T1,strongly ER+,HER2- invasive breast cancer,does NET improve global HRQoL over 15 months and increase breast BCS rates? Patients will be randomised 1:1 to either the intervention (NET) arm (6 +/- 1 months of NET followed by surgery and adjuvant ET) or the control arm (2-4 weeks of presurgical NET and surgery within 2-4 weeks [up to 8 weeks permitted for trial purposes] followed by adjuvant ET). Both arms will receive ...

GO TO STUDY Go

Neurological

Impact of Semaglutide in Amyloid Positivity (ISAP)

The lack of effective treatments for dementia remains one of the key challenges to modern medicine and society. Its leading cause is Alzheimer’s disease (AD), a condition where proteins (called amyloid and tau) build up in the brain causing inflammation and loss of nerve cells. Importantly, we now know that this process begins decades before first symptoms of dementia appear offering an opportunity to stop it in its tracks with the right treatment. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a ...

GO TO STUDY Go

Injuries and accidents

Intramuscular tranexamic acid for the treatment of symptomatic mild traumatic brain injury in older adults: a randomised, double-blind, placebo-controlled trial.

Every year, over one million people in England and Wales suffer a mild Traumatic Brain Injury (TBI) needing hospital care. Bleeding into the brain is a common and serious complication of TBI and older adults are at highest risk. Even a small bleed into the brain can cause disability and some patients can die if the bleeding is more severe. We know that giving a drug called tranexamic acid as an infusion into the vein after a TBI reduces the ...

GO TO STUDY Go

Infection

Impact of Covid19 on Respiratory Syncytial Virus seasonality and disease severity in UK children (BronchStart)

Bronchiolitis is a very common winter disease that normally affects children less than one year of age. It is a common reason for parents and carers to bring their child to an Emergency Department (ED) and the frequent need for hospital admission means that paediatric units are at their capacity each winter. During the COVID19 pandemic the virus that causes bronchiolitis (Respiratory Syncytial Virus; RSV) disappeared meaning this winter there have been virtually no cases of bronchiolitis in the ...

GO TO STUDY Go

Generic health relevance Mental health

Sprint National Anaesthesia Project 3: an observational study of frailty, multimorbidity and delirium in older people in the perioperative period (SNAP3)

BACKGROUND More older people are undergoing surgery as the population ages and surgical care improves. Frailty is an age-related syndrome that increases an individual's vulnerability to adverse outcomes in response to illness, injury and surgery. Delirium is a period of temporarily altered, fluctuating consciousness, triggered by illness, surgery or environment. There is evidence that surgical outcomes are worse in patients with these conditions. AIMS The purpose of SNAP3 is to investigate which patients are frail and which are at risk ...

GO TO STUDY Go

Cancer and neoplasms Cardiovascular Reproductive health and childbirth Respiratory Stroke

Open-label randomised controlled trial of enhanced support and nicotine replacement therapy (NRT) offered for preloading, lapse recovery and smoking reduction: impact on smoking in pregnancy (SNAP3)

Nicotine replacement therapy (NRT) provides nicotine without toxins contained in cigarette smoke; when used with specialist support, it helps pregnant women stop smoking. The NRT instruction booklet includes use for preloading, reduction and lapse recovery; studies suggest that allowing to smoke and use NRT together helps with stopping. Currently, NHS stop smoking support advises pregnant women not to smoke when using NRT. This study will test whether relaxing this message could help pregnant women to quit and improve babies’ health. The ...

GO TO STUDY Go

Cancer and neoplasms

New Protocol Title: A Phase 1/2, First-in-Human Study of theMenin-KMT2A (MLL1)Inhibitor Bleximenib in Participants with Acute Leukemia Previous study title: A First in Human Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Participants with Acute Leukemia (cAMELot-1)

This is a first-in-human (FIH), open-label, non-randomised, multicentre, Phase 1 study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary clinical activity of JNJ-75276617 (the study medication) in adult participants with relapsed or refractory acute leukaemia harbouring KMT2A or NPM1 gene alterations. Leukaemia (cancer of the white blood cells) is diagnosed as acute leukaemia when it progresses quickly and aggressively, and usually requires immediate treatment. Acute leukaemia is classified according to the type of white blood cells affected: Acute ...

GO TO STUDY Go

Neurological

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)

The Evoke study is a randomised, double-blind, placebo-controlled trial to evaluate how effective and safe oral semaglutide is in patients with early Alzheimer’s disease. Alzheimer’s disease is a progressive disorder characterised by gradual cognitive and functional decline that ultimately leads to bodily dysfunction and death. Currently available treatments only provide symptomatic relief and there is a significant unmet need for treatments that can lower the rate of disease progression. Oral semaglutide is a Glucagon like peptide 1 receptor agonist (GLP1-RA), which is ...

GO TO STUDY Go

Cancer and neoplasms

Defining risk in smouldering myeloma (SMM) for early detection of multiple myeloma (COSMOS)

Myeloma(MM) is a common bone marrow cancer with over 5,000 patients diagnosed annually in the UK. Patients with MM have cancerous cells in their bone marrow that grow in an uncontrolled fashion and although new treatments have been developed for MM in the last 5 years, it remains an incurable disease, with nearly 3000 deaths yearly. MM is always preceded by defined precursor conditions, known as monoclonal gammopathy of uncertain significance (MGUS) and smouldering myeloma (SMM). However, only 7% of ...

GO TO STUDY Go

Cancer and neoplasms

A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previously untreated stage IA/IIA Hodgkin lymphoma - RADAR (RADAR)

The RADAR trial is a phase III trial investigating whether substituting brentuximab vedotin for bleomycin in standard chemotherapy for patients with previously untreated early stage Hodgkin Lymphoma (HL) can: • Help stop the lymphoma from coming back • Help more people reach a deep remission quickly • Improve patient survival • Cause less lung damage • Reduce the need for radiotherapy, and the rates of radiotherapy-related toxicities such as second cancers and heart disease. The current standard treatment for patients with early stage HL is 3-4 cycles of ABVD chemotherapy (doxorubicin, ...

GO TO STUDY Go